To Determine the Correlation between Dermatological Conditions and Diabetes Mellitus

Abstract

Background: Type 2 diabetes mellitus (T2DM) is a prevalent and complex disorder that need the expertise of other disciplines. However, the contribution of dermatologists in managing this condition has not been acknowledged. Aim: To determine the correlation between dermatological conditions and diabetes mellitus. Methodology: The research comprised a total of 110 people, including both males and females, who were 40 years of age or older and had probable diabetes mellitus. The research included participants who had dermatological disorders such as acanthosis nigricans, dermatophyte infections, psoriasis, endogenous eczema, chronic urticaria, generalized pruritus, lichen simplex chronicus, as well as concomitant comorbidities including obesity. Diabetes screening is the measurement of fasting blood glucose (FBG) and postprandial blood glucose (PPBG) levels using established laboratory protocols. Measurements of glycated hemoglobin (HbA1c) were conducted to evaluate the management of glucose over an extended period of time. Results: Among the participants, the most prevalent dermatological condition was acanthosis nigricans, affecting 25 participants (22.73%). Dermatophyte infections were observed in 20 participants (18.18%), and psoriasis was present in 15 participants (13.64%). Other conditions included endogenous eczema (9.09%), chronic urticaria (10.91%), generalized pruritus (7.27%), lichen simplex chronicus (9.09%), and obesity (9.09%). The prevalence of Diabetes Mellitus. Based on the American Diabetes Association (ADA) criteria, 45 participants (40.09%) had an FBG level of ≥ 126 mg/dL, and 50 participants (45.45%) had a PPBG level of ≥ 200 mg/dL. Additionally, 50 participants (45.45%) had an HbA1c level of ≥ 6.5%. Overall, 60 participants (54.55%) were diagnosed with diabetes mellitus. Conclusion: This research ultimately determined that dermatologists may have a pivotal role in combating the T2DM pandemic by early identification of T2DM and prompt beginning of therapy, perhaps decreasing the likelihood of severe consequences.